We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Sharps Compliance Corp. (“Sharps Compliance” or the “Company”) (NASDAQ: SMED) in connection with the proposed tender offer for the Company by an affiliate of Aurora Capital Partners.  Under the terms of the merger agreement, the Company’s shareholders will receive $8.75 in cash for each share of Sharps Compliance common stock owned.

Weiss Law is investigating whether (i) Sharps Compliance’s board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction, (ii) the $8.75 per-share merger consideration adequately compensates Sharps Compliance’s shareholders, and (iii) all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed. Notably, at least one analyst set a price target for the Company of $12.50 per share, $3.75 above the per-share merger consideration.